| 注册
首页|期刊导航|中国临床药理学杂志|鼠神经生长因子注射剂联合前列地尔注射液治疗突发性耳聋的临床研究

鼠神经生长因子注射剂联合前列地尔注射液治疗突发性耳聋的临床研究

马海珠 钟时勋

中国临床药理学杂志2018,Vol.34Issue(3):231-233,3.
中国临床药理学杂志2018,Vol.34Issue(3):231-233,3.DOI:10.13699/j.cnki.1001-6821.2018.03.012

鼠神经生长因子注射剂联合前列地尔注射液治疗突发性耳聋的临床研究

Clinical trial of mouse nerve growth factor injection combined with alprostadil injection in the treatment of sudden deafness

马海珠 1钟时勋2

作者信息

  • 1. 重庆市人民医院三院院区耳鼻咽喉科,重庆 400000
  • 2. 重庆医科大学附属第一医院耳鼻咽喉科,重庆 400016
  • 折叠

摘要

Abstract

Objective To observe the clinical efficacy and safety of mouse nerve growth factor injection combined with alprostadil injection in the treatment of sudden deafness.Methods A total of 96 patients with sudden deafness were divided into control and treatment groups with 48 cases per group.Control group was treated with alprostadil injection 10 μg per time,qd,intravenous injection.Treatment group was treated with mouse nerve growth factor injection 18 μg per time,qd,intramuscular injection,on the basis of control group.Two groups were treated for 10 d.The clinical efficacy,serum vascular cell adhesion factor 1 (sVCAM-1),vascular endothelial cadherin (VE-cadherin),high mobility group protein-1 (HMGB1) and adverse drug reactions were compared between two groups.Results After treatment,the total effective rates of treatment and control groups were 93.75% (45 cases/48 cases) and 75.00% (36 cases /48 cases) with significant difference (P < 0.05).After treatment,the main indexes in treatment and control groups were compared:sVCAM-1 were (199.20 ±21.50) and (242.99 ± 21.97) ng · mL-1,VE-cadherin were (2.76 ±0.37) and (3.71 ±0.45) mg · L-1,HMGB1 were (1.78 ±0.25) and (2.55 ±0.31) mg · L-1,the differences were statistically significant (all P < 0.05).The adverse drug reactions in treatment group were injection site pain,which in control group were headache and dizziness.The total incidences of adverse drug reactions in treatment and control groups were 6.25% and 10.42% without significant difference (P > 0.05).Conclusion Mouse nerve growth factor combined with alprostadil injection has a definitive clinical efficacy in the treatment of sudden deafness,which can effectively reduce the expression of serum sVCAM-1,VE-cadherin and HMGB1,without increasing the incidence of adverse drug reactions.

关键词

鼠神经生长因子注射剂/前列地尔注射液/突发性耳聋/安全性

Key words

mouse nerve growth factor injection/alprostadil injection/sudden deafness/safety

分类

医药卫生

引用本文复制引用

马海珠,钟时勋..鼠神经生长因子注射剂联合前列地尔注射液治疗突发性耳聋的临床研究[J].中国临床药理学杂志,2018,34(3):231-233,3.

基金项目

国家医学教育发展中心医学研究课题资助项目(2010-22-04-055) (2010-22-04-055)

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文